Clinical Pharmacology of Gastrointestinal and Liver Disease An Issue of Gastroenterology Clinics
Please note that due to a system merger our fulfilment system will be down beginning September 22nd with an anticipated date to begin shipping orders October 10th. We would like to apologize for any inconvenience by offering you a special 20% discount on select products. Please use Promotional Code 12760. Click here for promotion details.
Dr. Hunt has assembled a group of top experts to discuss the newest and most successful medical therapies to treat gastrointestinal diseases. The issue is divided into sections devoted to each of these diseases states or disorders: acid-related disorders, functional gastrointestinal disorders, inflammatory bowel disease, gastrointestinal oncology, and hepatitis; the last 2 articles address the future directions in gastrointestinal pharmacotherapy. Articles of special interest include those on Anti-TNFa Drugs and New Biological Drugs for IBD, 5-ASA Drugs and Modified Formulations, and Potential for Manipulation of the Microbiome in Gastrointestional Disease.
By Richard H. Hunt, MB, FRCP, FRCPEd, FRCPC, FACG, AGAF, Professor of Medicine, Division of Gastroenterology, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada
- Imprint: Saunders
- ISBN: 978-1-4377-2524-7
- Copyright: 2010